Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
InVivo Therapeutics Holdings Corp. NVIV
$1.32
-$0.03 (-1.95%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
3890212.00000000
-
week52high
13.77
-
week52low
0.81
-
Revenue
0
-
P/E TTM
0
-
Beta
0.82422100
-
EPS
-7.04000000
-
Last Dividend
0.00000000
-
Next Earnings Date
07 ноя 2022 г. в 21:00
Описание компании
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Raymond James | Strong Buy | 25 ноя 2020 г. | |
| Ladenburg Thalmann | Buy | 25 ноя 2020 г. | |
| Raymond James | Outperform | Strong Buy | 05 мая 2017 г. |
| Ladenburg Thalmann | Buy | 21 июл 2016 г. | |
| Raymond James | Strong Buy | 07 июл 2016 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| CHRISTOPHER RICHARD | A | 20800 | 20800 | 17 ноя 2022 г. |
| Morrison Christina | A | 4200 | 4200 | 17 ноя 2022 г. |
| MERRIFIELD C ANN | A | 4200 | 4200 | 17 ноя 2022 г. |
| MARSHAK DANIEL R | A | 4200 | 4200 | 17 ноя 2022 г. |
| Hamel Heather | A | 13400 | 13400 | 17 ноя 2022 г. |
| ROBERTS RICHARD JOHN | A | 4200 | 4200 | 17 ноя 2022 г. |
| ROSENTHAL BOB | A | 4200 | 4200 | 17 ноя 2022 г. |
| Toselli Richard M. | A | 61000 | 61000 | 17 ноя 2022 г. |
| Toselli Richard M. | D | 6201 | 16 | 21 дек 2021 г. |
| Toselli Richard M. | D | 6217 | 21 | 21 июн 2021 г. |
Новостная лента
Why Is InVivo Therapeutics (NVIV) Stock Down 34% Today?
InvestorPlace
07 окт 2022 г. в 10:25
Source: ra2 studio/Shutterstock InVivo Therapeutics (NASDAQ: NVIV ) stock is on the move Friday after the company reached a deal for a direct offering of its shares. The registered direct offering has InVivo Therapeutics agreeing to sell 523,810 shares of NVIV stock to a single institutional investor.